|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online October 30, 2006
doi: 10.1242/10.1242/jcs.03225
Commentary |
1 Biocenter Oulu and Department of Biochemistry, University of Oulu, FIN-90014 Oulu, Finland
2 Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
* Author for correspondence (e-mail: maurizio.molinari{at}irb.unisi.ch)
Accepted 23 August 2006
 |
Summary |
|---|
 Top Summary IntroductionGlycoprotein folding and quality...ERAD: disposal of folding...Conclusions and PerspectivesReferences |
|---|
Key words: ER, N-glycans, Protein folding, Quality control, ER-associated degradation, calnexin, EDEM
|
Introduction |
|---|
|
TopSummaryIntroductionGlycoprotein folding and quality...ERAD: disposal of folding...Conclusions and PerspectivesReferences |
|---|
). Access to the calnexin/calreticulin system requires removal of the two outermost glucose residues displayed on branch A of the N-glycan by the sequential action of glycanases GI and GII. Whether there are further contacts, beyond the glycan, between glycoprotein substrates and calnexin/calreticulin is a matter of ongoing investigation (reviewed by Williams, 2006). GII-catalyzed removal of the third glucose residue follows the dissociation of folding substrates from calnexin and is required for release of native polypeptides from the ER and transport to their final destination. The folding sensor UGT1 adds back a terminal glucose to promote re-association of non-native polypeptides released from calnexin, thus prolonging their retention in the ER folding environment. Cycles of de-/re-glucosylation might be protracted until the polypeptide released from calnexin fulfils quality control requirements.
|
1,2-linked mannose residues. Mannose removal initially reduces the activity of de- and reglucosylating enzymes on N-glycans exposed by non-native proteins (Grinna and Robbins, 1980; Sousa et al., 1992). Cleavage of the terminal mannose on branch A, the only acceptor for the UGT1-catalyzed re-glucosylation, results in the irreversible exclusion of the folding-defective polypeptide from the calnexin chaperone system. Hence this event interrupts futile folding attempts and prepares the terminally misfolded polypeptide for retrotranslocation into the cytosol and proteasome-operated disposal, a process known as ER-associated degradation (ERAD). |
Glycoprotein folding and quality control |
|---|
|
TopSummaryIntroductionGlycoprotein folding and quality...ERAD: disposal of folding...Conclusions and PerspectivesReferences |
|---|
1,2-linked glucose residue by GI and of the first 1,3-linked glucose by GII generates the Glc1-Man9-GlcNAc2 trimming intermediate that allows the polypeptide to associate with calnexin (and calreticulin) (Fig. 2, Step 1). The first de-glucosylation step catalyzed by GI (removal of glucose 1, Fig. 1A) occurs as soon as the core glycan has been transferred to the nascent chain by OST. Removal of glucose 2 by GII is slower and regulated (Daniels et al., 2003; Deprez et al., 2005; Wang et al., 2005). GII is an unusual glycosidase that comprises one catalytic subunit () and one mannose 6-phosphate receptor-like subunit (ß). According to a model recently proposed by Helenius and co-workers, the correct positioning of the first 1,3 glucose (glucose 2) in the active site of GII requires association of the GII ß-subunit with the tetramannosyl branch of a second N-glycan on the polypeptide chain (trans-activation of GII trimming of the middle glucose) (Deprez et al., 2005). Therefore, the generation of the monoglucosylated calnexin ligand must await, at least in some cases, the correct positioning of a second N-glycan on the nascent chain or the engagement of a second N-glycosylated protein. Trimming of the second glucose is nevertheless accomplished before synthesis of the polypeptide chain is completed – i.e. in a matter of a few minutes. Hence, co-translational association of substrates with calnexin and calreticulin has been observed in microsomes and in living cells (Chen et al., 1995; Hebert et al., 1997; Molinari and Helenius, 2000).
|
; Leach et al., 2002). Polypeptides emerging from the translocon complex enter a protected environment formed by the translocon, the OST subunits, the glucosidases, calnexin, ERp57 and other luminal factors that prevent the unstructured polypeptide interacting with other unstructured nascent chains. This substantially decreases the probability of forming aberrant homo- and hetero-oligomeric aggregates. Many proteins that enter the secretory pathway contain structure-stabilizing disulfide bonds. Formation of these is often the rate-limiting reaction in protein folding in the ER lumen and is catalyzed by members of the PDI family. The human ER lumen contains about 20 distinct PDI-family members (Ellgaard and Ruddock, 2005). We know little about their regulation, tissue-specific distribution, in vivo roles in protein biogenesis and/or turnover and any functional overlap with each other or ER-resident chaperones. However, the association of ERp57 with calnexin and calreticulin makes it the primary contender for the PDI that assists glycopolypeptide maturation (Molinari and Helenius, 1999; Oliver et al., 1997; Zapun et al., 1998). Importantly, ERp57 is the first oxidoreductase for which knockout mammalian cell lines have been reported (Garbi et al., 2006; Soldà et al., 2006) (see below).
Insight from chaperone knockouts
Knocking out individual components of the calnexin chaperone system is paving the way for a deeper understanding of the mechanisms of protein folding and quality control in the mammalian ER. In recent years, murine fibroblasts lacking calreticulin (Mesaeli et al., 1999), calnexin (Denzel et al., 2002), UGT1 (Molinari et al., 2005) or ERp57 (Garbi et al., 2006; Soldà et al., 2006) have been reported. All of these knockouts result in embryonic lethality in mice, except for the calnexin knockout, which causes a severe and progressive pathology characterized by impaired growth and motor disorders that eventually lead to premature death (Denzel et al., 2002). By contrast, at the cellular level, all of these knockouts are at first sight well tolerated. Viability, proliferation, morphology and stress levels are indistinguishable between wild-type and chaperone-deleted cells, which indicates that deletion of one member of the system does not cause large-scale protein misfolding. Although most polypeptides mature normally in cells lacking calnexin or calreticulin, there are at least two relevant exceptions: influenza virus hemagglutinin (HA) exhibits substantial folding defects when expressed in cells lacking calnexin (Molinari et al., 2004; Pieren et al., 2005); and MHC class I molecules show loading with sub-optimal peptides and premature release at the surface of calreticulin-deficient cells (Gao et al., 2002). Similarly, in ERp57-deleted cells, influenza HA (Soldà et al., 2006) and class I MHC molecules (Garbi et al., 2006) are the only model glycoproteins, among those analyzed so far, whose folding/export is significantly affected. Analyses of ERp57-deleted cells have led to the identification of at least one PDI family member, ERp72, which can act as a surrogate chaperone that catalyses intra- and inter-molecular disulfide bond formation when ERp57 is absent (Soldà et al., 2006). ERp72 shares the residues that in ERp57 are involved in association with the calnexin/calreticulin P-domains (Ellgaard and Ruddock, 2005); however, in contrast to ERp57, ERp72 still associates with substrates following inhibition of their binding to calnexin (Soldà et al., 2006).
Release from the calnexin chaperone system
Release from calnexin/calreticulin is followed by GII-catalysed cleavage of the innermost glucose residue from the N-glycan. The mammalian ER contains a folding sensor, UGT1, which checks the structure of the released polypeptides and adds back a glucose residue on the terminal 1,2-linked mannose residue on branch A of those polypeptides that have not yet attained their native conformation. There are conflicting data regarding a requirement for the proximity of the non-native region and the re-glucosylated N-glycan (Ritter et al., 2005; Taylor et al., 2004). In any case, re-glucosylation promotes re-association of the immature polypeptide with the ER lectins (Parodi, 2000). A re-glucosylation activity is absent in Saccharomyces cerevisiae. It is present, but dispensable for viability, in Schizosaccharomyces pombe, in which most polypeptides reach the native conformation in a single round of binding to calnexin (Fanchiotti et al., 1998). Less information is available about the requirement for mammalian glycoproteins to cycle in the calnexin chaperone system to acquire native conformation. At least two recombinant proteins, the T cell receptor -subunit (Van Leeuwen and Kearse, 1997) and transferrin (Wada et al., 1997), are subjected to repeated, almost frenetic (the t1/2 of the terminal glucose is <10 minutes) GII/UGT1-catalyzed, de-/re-glucosylation cycles during maturation. However, as in S. pombe, the majority of newly synthesized mammalian glycoproteins seems to acquire a transport-competent structure in a single round of association with the ER lectins. Hence, UGT1 deletion does not substantially accelerate the overall kinetics of polypeptide release from calnexin and the ER (Molinari et al., 2005) (T. Soldà, R. J. Kaufman and M.M., unpublished results).
Deletion of UGT1 does not result in a reduction in ER quality control, thus revealing that this enzyme is not the gatekeeper that prevents non-native polypeptides exiting the ER. Instead UGT1 delays the hand off of folding-defective polypeptides from the calnexin system to the systems that regulate the retrotranslocation of misfolded polypeptides into the cytosol for proteasome-mediated disposal (Molinari et al., 2005) (Fig. 2, step 6). Surprisingly, differences in the release of terminally misfolded substrates from calnexin in wild-type and UGT1-deficient cells emerge only upon persistent protein misfolding, 60 minutes after association of the substrate with calnexin. Thus, release from calnexin (steps 2 and 2a in Fig. 2) might initially be very slow and polypeptides are likely to explore conformations while trapped in the folding cage formed by calnexin and ERp57 (Molinari et al., 2005).
|
ERAD: disposal of folding-defective glycopolypeptides |
|---|
|
TopSummaryIntroductionGlycoprotein folding and quality...ERAD: disposal of folding...Conclusions and PerspectivesReferences |
|---|
; Meusser et al., 2005).
The finding that inhibition of mannose removal from N-glycans protects folding-defective polypeptides from ERAD (Su et al., 1993) led to the concept of the `mannose-timer' (Helenius, 1994). According to this model, removal of mannose residues from N-glycans terminates the maturation phase and initiates a series of events, still incompletely characterized, that eventually lead to retrotranslocation of the terminally misfolded polypeptide into the cytosol. By contrast, protection from de-mannosylation prolongs the lag phase that precedes the onset of degradation of the misfolded glycoprotein by retarding release of the substrate from the calnexin chaperone system (de Virgilio et al., 1999; Molinari et al., 2002; Wu et al., 2003).
Numerous studies with inhibitors in mammalian cells revealed the active involvement of kifunensine-sensitive 1,2-mannosidase(s) in ERAD regulation (Cabral et al., 2001; Hebert et al., 2005; Helenius and Aebi, 2004; Herscovics, 2001; Lederkremer and Glickman, 2005). Other work has shown that N-glycans on folding-defective polypeptides are extensively processed to Man5-6 configurations by the removal of 1,2-linked mannoses (light-green circles in Fig. 1A) (Ermonval et al., 2001; Foulquier et al., 2004; Foulquier et al., 2002; Frenkel et al., 2003; Hosokawa et al., 2003; Kitzmuller et al., 2003). Moreover, removal of an 1,2-linked mannose is required for degradation of misfolded proteins expressed in mutant cell lines [e.g. B3F7 and MadIA214 (Ermonval et al., 2001)] in which the only cleavable residue is the terminal mannose on chain A (Fig. 1B). Removal of this mannose residue, the only acceptor for UGT-catalyzed protein re-glucosylation, thus seems to be a potent signal for glycoprotein disposal in mammalian cells because it results in the irreversible interruption of futile folding attempts in the calnexin cycle. Which protein(s) perform the extensive mannose trimming observed during preparation of the folding-defective polypeptides for proteasomal disposal is still a matter of debate and extensive research. At least three possibilities exist: (1) co-sequestration of ERAD candidates and ER -mannosidase I in specialized sub-regions of the ER (Frenkel et al., 2003) in which the mannosidase concentration reaches levels similar to those shown in vitro to cause extensive mannose removal (Herscovics et al., 2002; Wu et al., 2003); (2) intervention of Golgi endo-mannosidase(s); (3) intervention of a new class of recently characterized mannosidase-like proteins, EDEM1, EDEM2 and EDEM3 (Hirao et al., 2006; Mast et al., 2005; Molinari et al., 2003; Oda et al., 2003; Olivari et al., 2005; Olivari et al., 2006).
The EDEM family
EDEM1 (for ER degradation enhancing -mannosidase-like protein) was first described as a mannosidase relative containing a 450-residue domain that shares 35% sequence identity with the catalytic domain of ER -mannosidase (Fig. 3A). EDEM1 overexpression accelerates disposal of model glycoproteins expressed in mammalian cells (Hosokawa et al., 2001) by accelerating the exit of polypeptides undergoing futile folding attempts from the calnexin chaperone system (Molinari et al., 2003; Oda et al., 2003). EDEM1 was initially described as a type 2 membrane protein that is embedded in the ER membrane by its uncleaved signal sequence, which also serves to form a complex with calnexin (Oda et al., 2003). This model has been challenged by data showing that, in most cell lines, the signal sequence is efficiently cleaved, releasing the mature EDEM1 protein into the ER lumen (Olivari et al., 2005). Recently, two relatives, EDEM2 and EDEM3, have been cloned and characterized (Fig. 3A) (Hirao et al., 2006; Mast et al., 2005; Olivari et al., 2005).
|
). Mammalian cells use this pathway to increase their capacity for ERAD, which is easily saturated (Travers et al., 2000), in response to an increase in cargo load and/or accumulation of misfolded polypeptides (Olivari et al., 2005; Yoshida et al., 2003; Yoshida et al., 2006). RNA interference directed against EDEM proteins (Gong et al., 2005; Molinari et al., 2003) and inactivation of the Ire1/Xbp1 pathway that regulates their intralumenal level both result in the sub-optimal disposal of misfolded glycoproteins (Yoshida et al., 2003) and eventually prevent protein folding and reduce secretory capacity (Eriksson et al., 2004), thus revealing important cross-talk between the folding and ERAD machineries. However, how upregulation of EDEM proteins actually facilitates the degradation of folding-defective glycopolypeptides remains unclear.
Are EDEM proteins active 1,2 mannosidases?
Although EDEM1 is a mannosidase-like protein, it was originally described as a putative lectin rather than an active mannosidase because it lacks a specific disulfide bond conserved in mannosidases (Hosokawa et al., 2001). Accumulating evidence now shows that EDEM proteins could actually be active mannosidases. First, the disulfide absent in the EDEM proteins is not conserved among all mannosidases and is dispensable for glycanase activity. Second, sequence similarity between EDEM proteins and ER -mannosidase I is, significantly, restricted to the region containing the ()7 barrel catalytic domain of class I mannosidases. Despite the low level of sequence identity (35%), all catalytic residues are conserved and structure modelling indicates no difference in their location (Hosokawa et al., 2001; Karaveg and Moremen, 2005; Karaveg et al., 2005; Tempel et al., 2004) (Fig. 3B). Residues involved in the binding of kifunensine, a specific inhibitor of 1,2 mannosidases, are also conserved (Fig. 3D). Third, elevation of the intralumenal level of EDEM1 (Olivari et al., 2006) and EDEM3 (Hirao et al., 2006) substantially accelerates de-mannosylation of folding-defective polypeptides. Acceleration of mannose removal upon upregulation of EDEM1 also occurs in B3F7 cells, which are characterized by addition of aberrant oligosaccharides lacking branch B and C to nascent polypeptide chains (Fig. 1B). Thus, EDEM1 (and possibly EDEM2 and EDEM3) can remove the terminal branch A mannose, the only cleavable terminal mannose present in glycoproteins in this cell line and the only saccharide that can be reglucosylated by UGT to prolong retention of folding-defective polypeptides in the calnexin cycle (Olivari et al., 2006).
EDEM proteins as molecular chaperones
Recent evidence suggests that EDEM1 also accelerates ERAD by preventing the formation of disulfide-bonded dimers (Hosokawa et al., 2006) or covalent aggregates (Olivari et al., 2006) containing terminally misfolded glycoproteins released from calnexin. This chaperone-like activity is not linked to the capacity of EDEM to accelerate substrate de-mannosylation, because enzymatically inactive mutants of EDEM1 can still perform this function (Olivari et al., 2006).
From the ER lumen into the cytosol
Despite extensive studies, the molecular machinery and the translocation channel(s) used to retrotranslocate terminally misfolded polypeptides into the cytosol remain incompletely characterized. However, several pathways for the degradation of terminally misfolded ER proteins have been identified in screens of yeast strains lacking steps of the ERAD process (Wolf and Schafer, 2005). In yeast, specific machineries are involved in the detection of structural protein defects. The ERAD-L machinery detects luminal defects, the ERAD-C detects cytosolic defects and the ERAD-M detects structural defects in the transmembrane regions of newly synthesized polypeptides (Ahner and Brodsky, 2004; Denic et al., 2006; Ismail and Ng, 2006; Vashist and Ng, 2004). Some of the components of these pathways (e.g. Kar2p and PDI) have orthologues in higher eukaryotes. Others – for example, the ER lectin Yos9p, which belongs to a multimeric complex involved in the recognition of proteins with luminal defects – do not yet have functional equivalents (reviewed by Ismail and Ng, 2006).
The mechanisms of ERAD in metazoans are less well characterized but certainly more complex than those of unicellular eukaryotes. In mammalian cells, a `hand off' of folding-defective polypeptides from the calnexin/calreticulin system to the BiP chaperone system has been shown to exist (Cabral et al., 2002; Molinari et al., 2002; Molinari et al., 2005). The rate of the transfer of ERAD candidates from one chaperone system to another is regulated by sugar-processing events that are absent in yeast, such as substrate re-glucosylation that prolongs retention in the protective calnexin/ERp57 folding cage and extensive de-mannosylation. In addition, the association of PDI with the misfolded polypeptide before retrotranslocation into the cytosol has been shown (Molinari et al., 2002). This has been interpreted as an involvement of this ER oxidoreductase in the reduction of disulfide bonds, which is required for retrotranslocation of ERAD candidates (Fagioli and Sitia, 2001; Tortorella et al., 1998) and of subunits of bacterial toxin, which co-opt the same route (Gillece et al., 1999; Tsai et al., 2001). The precise composition of the ER channel(s) used to retrotranslocate terminally misfolded polypeptides in the cytosol is still unknown. Retrotranslocation has long been known to involve Sec61, a proteinaceous channel also utilized by proteins entering co-translationally into the ER (Pilon et al., 1997; Plemper et al., 1997; Zhou and Schekman, 1999), even though exceptions are known (Huyer et al., 2004). Additional proteins termed derlins have recently been implicated (Lilley and Ploegh, 2004; Ye et al., 2004) and these associate with the EDEM proteins (Oda et al., 2006). The mechanisms connecting retrotranslocation and proteasome-mediated degradation are unclear, but many substrates accumulate in the ER lumen when proteasome activity is blocked, which indicates that retrotranslocation and degradation are coupled reactions (Mancini et al., 2000; Mayer et al., 1998; Molinari et al., 2002).
|
Conclusions and Perspectives |
|---|
|
TopSummaryIntroductionGlycoprotein folding and quality...ERAD: disposal of folding...Conclusions and PerspectivesReferences |
|---|
Over the past few years a number of significant advances have been made in our understanding of this field. Amongst the most relevant are certainly those that shed light on the important regulatory role of the polypeptide-associated oligosaccharides. Several recent reviews cover the roles of N-glycans and ER or intermediate compartment lectins in export of native proteins from the ER (Hauri et al., 2002; Hebert et al., 2005; Schrag et al., 2003) and that of cytosolic lectins in directing misfolded proteins to the cytosolic proteasome (Hebert et al., 2005; Yoshida, 2003). Here we have focused on the important role of N-glycans, ER-resident lectins and N-glycan-processing enzymes in protein quality control in the mammalian ER.
The glycoprotein-dedicated chaperone system is used by many, if not all, newly synthesized cellular glycoproteins. It is also exploited for maturation of glycosylated viral gene products expressed in virus-infected cells. The machinery is highly redundant, and surrogate chaperones and enzymes can be used by nascent chains. Indeed, deletion of calnexin (Denzel et al., 2002), calreticulin (Mesaeli et al., 1999), ERp57 (Garbi et al., 2006; Soldà et al., 2006) or UGT1 (Molinari et al., 2005) produces very little phenotypic effect in cell lines and only very few model substrates that dramatically suffer from individual deletions of members of this folding machinery have been identified. However, the devastating consequences of lack of these proteins in the corresponding murine models and the lethal outcome of an inherited glucosidase I deficiency show the importance of the glycoprotein-dedicated machinery for embryogenesis and/or homeostasis of specific tissues and organs (De Praeter et al., 2000; Pieren et al., 2005).
Despite the highly sophisticated chaperone machineries that assist protein biogenesis in the mammalian ER, a certain percentage of newly synthesized proteins [up to 30% in some studies (Schubert et al., 2000)] never acquires a native, transport-competent structure. In addition, mutations or changes in biophysical conditions can dramatically lower the protein folding efficiency; hence rapid disposal of aberrant products is crucial to maintain ER homeostasis. The consequences of the accumulation and deposition of misfolded proteins – for example, in human ER-storage diseases – are cell death, tissue damage and organ failure (Aridor and Hannan, 2000).
A range of tools are available to dissect the mechanisms of ER homeostasis – for example, viral products that elicit rapid degradation of class I MHC molecules, bacterial toxins that co-opt the retrotranslocation machinery to enter the host cell cytosol, model ERAD substrates to be expressed at high levels in the cell line of interest, organisms such as S. cerevisiae that are easy to manipulate genetically and that share a simplified version of the machineries and mechanisms operating in metazoans, and inhibitors of specific enzymatic pathways. Every experimental approach offers advantages and drawbacks, and caution must be used in any attempt to generalize the findings. For example, the disposal of class I MHC molecules triggered by cytomegalovirus gene products is an exceptionally fast process. It by-passes the requirement for mannose removal from the N-glycans on the ERAD substrate and causes accumulation of the protein to be degraded in the cytosol upon inhibition of the proteasome, whereas for most ERAD substrates retrotranslocation from the ER into the cytosol is coupled to degradation (Mancini et al., 2000; Mayer et al., 1998; Molinari and Sitia, 2005). In addition, one must be cautious about generalizing from data obtained from a single species or a single model substrate. Many components of the ER quality control machinery appear to be conserved, but several functions (e.g. the cycling in the calnexin chaperone system or the extensive de-mannosylation that ERAD substrates are subjected to) are only present in higher eukaryotes, and other more subtle differences may exist. Furthermore, similar caution must be exercised with the use of inhibitors (most of which have not been comprehensively tested for specificity), temperature shifts (which will have effects on many different processes) and conclusions drawn about normal physiological pathways on the basis of knockout and knock-down studies given the potential functional redundancy in the system. However, there is no doubt that the comparative quantitative study of all these model systems can be combined to give a deep understanding of the pathways that work over the range of conditions under which each cell must operate.
|
Acknowledgments |
|---|
|
References |
|---|
|
TopSummaryIntroductionGlycoprotein folding and quality...ERAD: disposal of folding...Conclusions and PerspectivesReferences |
|---|
Ahner, A. and Brodsky, J. L. (2004). Checkpoints in ER-associated degradation: excuse me, which way to the proteasome? Trends Cell Biol. 14, 474-478.[CrossRef][Medline]
Aridor, M. and Hannan, L. A. (2000). Traffic jam: a compendium of human diseases that affect intracellular transport processes. Traffic 1, 836-851.[CrossRef][Medline]
Cabral, C. M., Liu, Y. and Sifers, R. N. (2001). Dissecting glycoprotein quality control in the secretory pathway. Trends Biochem. Sci. 26, 619-624.[CrossRef][Medline]
Cabral, C. M., Liu, Y., Moremen, K. W. and Sifers, R. N. (2002). Organizational diversity among distinct glycoprotein endoplasmic reticulum-associated degradation programs. Mol. Biol. Cell 13, 2639-2650.
Chen, W., Helenius, J., Braakman, I. and Helenius, A. (1995). Cotranslational folding and calnexin binding during glycoprotein synthesis. Proc. Natl. Acad. Sci. USA 92, 6229-6233.
Daniels, R., Kurowski, B., Johnson, A. E. and Hebert, D. N. (2003). N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin. Mol. Cell 11, 79-90.[CrossRef][Medline]
De Praeter, C. M., Gerwig, G. J., Bause, E., Nuytinck, L. K., Vliegenthart, J. F., Breuer, W., Kamerling, J. P., Espeel, M. F., Martin, J. J., De Paepe, A. M. et al. (2000). A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. Am. J. Hum. Genet. 66, 1744-1756.[CrossRef][Medline]
de Virgilio, M., Kitzmuller, C., Schwaiger, E., Klein, M., Kreibich, G. and Ivessa, N. E. (1999). Degradation of a short-lived glycoprotein from the lumen of the endoplasmic reticulum: the role of N-linked glycans and the unfolded protein response. Mol. Biol. Cell 10, 4059-4073.
Denic, V., Quan, E. M. and Weissman, J. S. (2006). A luminal surveillance complex that selects misfolded glycoproteins for ER-associated degradation. Cell 126, 349-359.[CrossRef][Medline]
Denzel, A., Molinari, M., Trigueros, C., Martin, J. E., Velmurgan, S., Brown, S., Stamp, G. and Owen, M. J. (2002). Early postnatal death and motor disorders in mice congenitally deficient in calnexin expression. Mol. Cell. Biol. 22, 7398-7404.
Deprez, P., Gautschi, M. and Helenius, A. (2005). More than one glycan is needed for ER glucosidase II to allow entry of glycoproteins into the calnexin/calreticulin cycle. Mol. Cell 19, 183-195.[CrossRef][Medline]
Ellgaard, L. and Ruddock, L. W. (2005). The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep. 6, 28-32.[CrossRef][Medline]
Ellgaard, L., Molinari, M. and Helenius, A. (1999). Setting the standards: quality control in the secretory pathway. Science 286, 1882-1888.
Eriksson, K. K., Vago, R., Calanca, V., Galli, C., Paganetti, P. and Molinari, M. (2004). EDEM contributes to maintenance of protein folding efficiency and secretory capacity. J. Biol. Chem. 279, 44600-44605.
Ermonval, M., Kitzmuller, C., Mir, A. M., Cacan, R. and Ivessa, N. E. (2001). N-glycan structure of a short-lived variant of ribophorin I expressed in the MadIA214 glycosylation-defective cell line reveals the role of a mannosidase that is not ER mannosidase I in the process of glycoprotein degradation. Glycobiology 11, 565-576.
Fagioli, C. and Sitia, R. (2001). Glycoprotein quality control in the endoplasmic reticulum. Mannose trimming by endoplasmic reticulum mannosidase I times the proteasomal degradation of unassembled immunoglobulin subunits. J. Biol. Chem. 276, 12885-12892.
Fanchiotti, S., Fernandez, F., D'Alessio, C. and Parodi, A. J. (1998). The UDP-Glc:Glycoprotein glucosyltransferase is essential for Schizosaccharomyces pombe viability under conditions of extreme endoplasmic reticulum stress. J. Cell Biol. 143, 625-635.
Foulquier, F., Harduin-Lepers, A., Duvet, S., Marchal, I., Mir, A. M., Delannoy, P., Chirat, F. and Cacan, R. (2002). The unfolded protein response in a dolichyl phosphate mannose-deficient Chinese hamster ovary cell line points out the key role of a demannosylation step in the quality-control mechanism of N-glycoproteins. Biochem. J. 362, 491-498.[CrossRef][Medline]
Foulquier, F., Duvet, S., Klein, A., Mir, A. M., Chirat, F. and Cacan, R. (2004). Endoplasmic reticulum-associated degradation of glycoproteins bearing Man5GlcNAc2 and Man9GlcNAc2 species in the MI8-5 CHO cell line. Eur. J. Biochem. 271, 398-404.[Medline]
Frenkel, Z., Gregory, W., Kornfeld, S. and Lederkremer, G. Z. (2003). Endoplasmic reticulum-associated degradation of mammalian glycoproteins involves sugar chain trimming to Man6-5GlcNAc2. J. Biol. Chem. 278, 34119-34124.
Frickel, E. M., Riek, R., Jelesarov, I., Helenius, A., Wuthrich, K. and Ellgaard, L. (2002). TROSY-NMR reveals interaction between ERp57 and the tip of the calreticulin P-domain. Proc. Natl. Acad. Sci. USA 99, 1954-1959.
Gao, B., Adhikari, R., Howarth, M., Nakamura, K., Gold, M. C., Hill, A. B., Knee, R., Michalak, M. and Elliott, T. (2002). Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin. Immunity 16, 99-109.[CrossRef][Medline]
Garbi, N., Tanaka, S., Momburg, F. and Hammerling, G. J. (2006). Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57. Nat. Immunol. 7, 93-102.[CrossRef][Medline]
Gillece, P., Luz, J. M., Lennarz, W. J., de la Cruz, F. J. and Romisch, K. (1999). Export of a cysteine-free misfolded secretory protein from the endoplasmic reticulum for degradation requires interaction with protein disulfide isomerase. J. Cell Biol. 147, 1443-1456.
Gong, Q., Keeney, D. R., Molinari, M. and Zhou, Z. (2005). Degradation of trafficking-defective long QT syndrome type II mutant channels by the ubiquitin-proteasome pathway. J. Biol. Chem. 280, 19419-19425.
Grinna, L. S. and Robbins, P. W. (1980). Substrate specificities of rat liver microsomal glucosidases which process glycoproteins. J. Biol. Chem. 255, 2255-2258.
Hauri, H. P., Nufer, O., Breuza, L., Tekaya, H. B. and Liang, L. (2002). Lectins and protein traffic early in the secretory pathway. Biochem. Soc. Symp. 69, 73-82.[Medline]
Hebert, D. N., Zhang, J. X., Chen, W., Foellmer, B. and Helenius, A. (1997). The number and location of glycans on influenza hemagglutinin determine folding and association with calnexin and calreticulin. J. Cell Biol. 139, 613-623.
Hebert, D. N., Garman, S. C. and Molinari, M. (2005). The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrates as protein maturation and quality-control tags. Trends Cell Biol. 15, 364-370.[CrossRef][Medline]
Helenius, A. (1994). How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum. Mol. Biol. Cell 5, 253-265.[Medline]
Helenius, A. and Aebi, M. (2004). Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem. 73, 1019-1049.[CrossRef][Medline]
Herscovics, A. (2001). Structure and function of Class I alpha 1,2-mannosidases involved in glycoprotein synthesis and endoplasmic reticulum quality control. Biochimie 83, 757-762.[Medline]
Herscovics, A., Romero, P. A. and Tremblay, L. O. (2002). The specificity of the yeast and human class I ER alpha 1,2-mannosidases involved in ER quality control is not as strict previously reported. Glycobiology 12, 14G-15G.[Medline]
Hirao, K., Natsuka, Y., Tamura, T., Wada, I., Morito, D., Natsuka, S., Romero, P., Sleno, B., Tremblay, L. O., Herscovics, A. et al. (2006). EDEM3, a soluble EDEM homolog, enhances glycoprotein ERAD and mannose trimming. J. Biol. Chem. 281, 9650-9658.
Hosokawa, N., Wada, I., Hasegawa, K., Yorihuzi, T., Tremblay, L. O., Herscovics, A. and Nagata, K. (2001). A novel ER {alpha}-mannosidase-like protein accelerates ER-associated degradation. EMBO Rep. 2, 415-422.[Medline]
Hosokawa, N., Tremblay, L. O., You, Z., Herscovics, A., Wada, I. and Nagata, K. (2003). Enhancement of endoplasmic reticulum (ER) degradation of misfolded Null Hong Kong alpha1-antitrypsin by human ER mannosidase I. J. Biol. Chem. 278, 26287-26294.
Hosokawa, N., Wada, I., Natsuka, Y. and Nagata, K. (2006). EDEM accelerates ERAD by preventing aberrant dimer formation of misfolded alpha1-antitrypsin. Genes Cells 11, 465-476.
Huyer, G., Piluek, W. F., Fansler, Z., Kreft, S. G., Hochstrasser, M., Brodsky, J. L. and Michaelis, S. (2004). Distinct machinery is required in Saccharomyces cerevisiae for the endoplasmic reticulum-associated degradation of a multispanning membrane protein and a soluble luminal protein. J. Biol. Chem. 279, 38369-38378.
Ismail, N. and Ng, D. T. (2006). Have you HRD? Understanding ERAD is DOAble! Cell 126, 237-239.[CrossRef][Medline]
Karaveg, K. and Moremen, K. W. (2005). Energetics of substrate binding and catalysis by class 1 (glycosylhydrolase family 47) alpha-mannosidases involved in N-glycan processing and endoplasmic reticulum quality control. J. Biol. Chem. 280, 29837-29848.
Karaveg, K., Siriwardena, A., Tempel, W., Liu, Z. J., Glushka, J., Wang, B. C. and Moremen, K. W. (2005). Mechanism of class 1 (glycosylhydrolase family 47) {alpha}-mannosidases involved in N-glycan processing and endoplasmic reticulum quality control. J. Biol. Chem. 280, 16197-16207.
Kitzmuller, C., Caprini, A., Moore, S. E., Frenoy, J. P., Schwaiger, E., Kellermann, O., Ivessa, N. E. and Ermonval, M. (2003). Processing of N-linked glycans during endoplasmic-reticulum-associated degradation of a short-lived variant of ribophorin I. Biochem. J. 376, 687-696.[CrossRef][Medline]
Leach, M. R., Cohen-Doyle, M. F., Thomas, D. Y. and Williams, D. B. (2002). Localization of the lectin, ERp57 binding, and polypeptide binding sites of calnexin and calreticulin. J. Biol. Chem. 277, 29686-29697.
Lederkremer, G. Z. and Glickman, M. H. (2005). A window of opportunity: timing protein degradation by trimming of sugars and ubiquitins. Trends Biochem. Sci. 30, 297-303.[CrossRef][Medline]
Lilley, B. N. and Ploegh, H. L. (2004). A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429, 834-840.[CrossRef][Medline]
Mancini, R., Fagioli, C., Fra, A. M., Maggioni, C. and Sitia, R. (2000). Degradation of unassembled soluble Ig subunits by cytosolic proteasomes: evidence that retrotranslocation and degradation are coupled events. FASEB J. 14, 769-778.
Mast, S. W., Diekman, K., Karaveg, K., Davis, A., Sifers, R. N. and Moremen, K. W. (2005). Human EDEM2, a novel homolog of family 47 glycosidases, is involved in ER-associated degradation of glycoproteins. Glycobiology 15, 421-436.
Mayer, T. U., Braun, T. and Jentsch, S. (1998). Role of the proteasome in membrane extraction of a short-lived ER-transmembrane protein. EMBO J. 17, 3251-3257.[CrossRef][Medline]
Mesaeli, N., Nakamura, K., Zvaritch, E., Dickie, P., Dziak, E., Krause, K. H., Opas, M., MacLennan, D. H. and Michalak, M. (1999). Calreticulin is essential for cardiac development. J. Cell Biol. 144, 857-868.
Meusser, B., Hirsch, C., Jarosch, E. and Sommer, T. (2005). ERAD: the long road to destruction. Nat. Cell Biol. 7, 766-772.[CrossRef][Medline]
Molinari, M. and Helenius, A. (1999). Glycoproteins form mixed disulphides with oxidoreductases during folding in living cells. Nature 402, 90-93.[CrossRef][Medline]
Molinari, M. and Helenius, A. (2000). Chaperone selection during glycoprotein translocation into the endoplasmic reticulum. Science 288, 331-333.
Molinari, M. and Sitia, R. (2005). The secretory capacity of a cell depends on the efficiency of endoplasmic reticulum-associated degradation. Curr. Top. Microbiol. Immunol. 300, 1-15.[Medline]
Molinari, M., Galli, C., Piccaluga, V., Pieren, M. and Paganetti, P. (2002). Sequential assistance of molecular chaperones and transient formation of covalent complexes during protein degradation from the ER. J. Cell Biol. 158, 247-257.
Molinari, M., Calanca, V., Galli, C., Lucca, P. and Paganetti, P. (2003). Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle. Science 299, 1397-1400.
Molinari, M., Eriksson, K. K., Calanca, V., Galli, C., Cresswell, P., Michalak, M. and Helenius, A. (2004). Contrasting functions of calreticulin and calnexin in glycoprotein folding and ER quality control. Mol. Cell 13, 125-135.[CrossRef][Medline]
Molinari, M., Galli, C., Vanoni, O., Arnold, S. M. and Kaufman, R. J. (2005). Persistent glycoprotein misfolding activates the glucosidase II/UGT1-driven calnexin cycle to delay aggregation and loss of folding competence. Mol. Cell 20, 503-512.[CrossRef][Medline]
Oda, Y., Hosokawa, N., Wada, I. and Nagata, K. (2003). EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin. Science 299, 1394-1397.
Oda, Y., Okada, T., Yoshida, H., Kaufman, R. J., Nagata, K. and Mori, K. (2006). Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation. J. Cell Biol. 172, 383-393.
Olivari, S., Galli, C., Alanen, H., Ruddock, L. and Molinari, M. (2005). A novel stress-induced EDEM variant regulating endoplasmic reticulum-associated glycoprotein degradation. J. Biol. Chem. 280, 2424-2428.
Olivari, S., Cali, T., Salo, K. E., Paganetti, P., Ruddock, L. W. and Molinari, M. (2006). EDEM1 regulates ER-associated degradation by accelerating demannosylation of folding-defective polypeptides and by inhibiting their covalent aggregation. Biochem. Biophys. Res. Commun. 349, 1278-1284.[CrossRef][Medline]
Oliver, J. D., van der Wal, F. J., Bulleid, N. J. and High, S. (1997). Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins. Science 275, 86-88.
Parodi, A. J. (2000). Protein glucosylation and its role in protein folding. Annu. Rev. Biochem. 69, 69-93.[CrossRef][Medline]
Pieren, M., Galli, C., Denzel, A. and Molinari, M. (2005). The use of calnexin and calreticulin by cellular and viral glycoproteins. J. Biol. Chem. 280, 28265-28271.
Pilon, M., Schekman, R. and Romisch, K. (1997). Sec61p mediates export of a misfolded secretory protein from the endoplasmic reticulum to the cytosol for degradation. EMBO J. 16, 4540-4548.[CrossRef][Medline]
Plemper, R. K., Bohmler, S., Bordallo, J., Sommer, T. and Wolf, D. H. (1997). Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation. Nature 388, 891-895.[CrossRef][Medline]
Ritter, C., Quirin, K., Kowarik, M. and Helenius, A. (2005). Minor folding defects trigger local modification of glycoproteins by the ER folding sensor GT. EMBO J. 24, 1730-1738.[CrossRef][Medline]
Schrag, J. D., Procopio, D. O., Cygler, M., Thomas, D. Y. and Bergeron, J. J. (2003). Lectin control of protein folding and sorting in the secretory pathway. Trends Biochem. Sci. 28, 49-57.[CrossRef][Medline]
Schubert, U., Anton, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W. and Bennink, J. R. (2000). Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404, 770-774.[CrossRef][Medline]
Soldà, T., Garbi, N., Hammerling, G. J. and Molinari, M. (2006). Consequences of ERp57 deletion on oxidative folding of obligate and facultative clients of the calnexin cycle. J. Biol. Chem. 281, 6219-6226.
Sousa, M. C., Ferrero-Garcia, M. A. and Parodi, A. J. (1992). Recognition of the oligosaccharide and protein moieties of glycoproteins by the UDP-Glc:glycoprotein glucosyltransferase. Biochemistry 31, 97-105.[CrossRef][Medline]
Su, K., Stoller, T., Rocco, J., Zemsky, J. and Green, R. (1993). Pre-Golgi degradation of yeast prepro-alpha-factor expressed in a mammalian cell. Influence of cell type-specific oligosaccharide processing on intracellular fate. J. Biol. Chem. 268, 14301-14309.
Taylor, S. C., Ferguson, A. D., Bergeron, J. J. and Thomas, D. Y. (2004). The ER protein folding sensor UDP-glucose glycoprotein-glucosyltransferase modifies substrates distant to local changes in glycoprotein conformation. Nat. Struct. Mol. Biol. 11, 128-134.[CrossRef][Medline]
Tempel, W., Karaveg, K., Liu, Z. J., Rose, J., Wang, B. C. and Moremen, K. W. (2004). Structure of mouse Golgi {alpha}-mannosidase IA reveals the molecular basis for substrate specificity among Class 1 (Family 47 Glycosylhydrolase) {alpha}1,2-mannosidases. J. Biol. Chem. 279, 29774-29786.
Tortorella, D., Story, C. M., Huppa, J. B., Wiertz, E. J., Jones, T. R., Bacik, I., Bennink, J. R., Yewdell, J. W. and Ploegh, H. L. (1998). Dislocation of type I membrane proteins from the ER to the cytosol is sensitive to changes in redox potential. J. Cell Biol. 142, 365-376.
Travers, K. J., Patil, C. K., Wodicka, L., Lockhart, D. J., Weissman, J. S. and Walter, P. (2000). Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 101, 249-258.[CrossRef][Medline]
Tsai, B., Rodighiero, C., Lencer, W. I. and Rapoport, T. A. (2001). Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin. Cell 104, 937-948.[CrossRef][Medline]
Vallee, F., Karaveg, K., Herscovics, A., Moremen, K. W. and Howell, P. L. (2000). Structural basis for catalysis and inhibition of N-glycan processing class I alpha 1,2-mannosidases. J. Biol. Chem. 275, 41287-41298.
Van Leeuwen, J. E. and Kearse, K. P. (1997). Reglucosylation of N-linked glycans is critical for calnexin assembly with T cell receptor (TCR) alpha proteins but not TCRbeta proteins. J. Biol. Chem. 272, 4179-4186.
Vashist, S. and Ng, D. T. (2004). Misfolded proteins are sorted by a sequential checkpoint mechanism of ER quality control. J. Cell Biol. 165, 41-52.
Wada, I., Kai, M., Imai, S., Sakane, F. and Kanoh, H. (1997). Promotion of transferrin folding by cyclic interactions with calnexin and calreticulin. EMBO J. 16, 5420-5432.[CrossRef][Medline]
Wang, N., Daniels, R. and Hebert, D. N. (2005). The cotranslational maturation of the type I membrane glycoprotein tyrosinase: the heat shock protein 70 system hands off to the lectin-based chaperone system. Mol. Biol. Cell 16, 3740-3752.
Williams, D. B. (2006). Beyond lectins: the calnexin/calreticulin chaperone system of the endoplasmic reticulum. J. Cell Sci. 119, 615-623.
Wolf, D. H. and Schafer, A. (2005). CPY* and the power of yeast genetics in the elucidation of quality control and associated protein degradation of the endoplasmic reticulum. Curr. Top. Microbiol. Immunol. 300, 41-56.[Medline]
Wu, Y., Swulius, M. T., Moremen, K. W. and Sifers, R. N. (2003). Elucidation of the molecular logic by which misfolded alpha 1-antitrypsin is preferentially selected for degradation. Proc. Natl. Acad. Sci. USA 100, 8229-8234.
Ye, Y., Shibata, Y., Yun, C., Ron, D. and Rapoport, T. A. (2004). A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429, 841-847.[CrossRef][Medline]
Yoshida, H., Matsui, T., Hosokawa, N., Kaufman, R. J., Nagata, K. and Mori, K. (2003). A time-dependent phase shift in the mammalian unfolded protein response. Dev. Cell 4, 265-271.[CrossRef][Medline]
Yoshida, H., Oku, M., Suzuki, M. and Mori, K. (2006). pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response. J. Cell Biol. 172, 565-575.
Yoshida, Y. (2003). A novel role for N-glycans in the ERAD system. J. Biochem. 134, 183-190.
Zapun, A., Darby, N. J., Tessier, D. C., Michalak, M., Bergeron, J. J. and Thomas, D. Y. (1998). Enhanced catalysis of ribonuclease B folding by the interaction of calnexin or calreticulin with ERp57. J. Biol. Chem. 273, 6009-6012.
Zhou, M. and Schekman, R. (1999). The engagement of Sec61p in the ER dislocation process. Mol. Cell 4, 925-934.[CrossRef][Medline]
This article has been cited by other articles:
|
|
 |
|
  P. Bartoccioni, M. Rius, A. Zorzano, M. Palacin, and J. Chillaron Distinct classes of trafficking rBAT mutants cause the type I cystinuria phenotype Hum. Mol. Genet., June 15, 2008; 17(12): 1845 - 1854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Maruri-Avidal, S. Lopez, and C. F. Arias Endoplasmic Reticulum Chaperones Are Involved in the Morphogenesis of Rotavirus Infectious Particles J. Virol., June 1, 2008; 82(11): 5368 - 5380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bartoli, E. Gicquel, L. Barrault, T. Soheili, M. Malissen, B. Malissen, N. Vincent-Lacaze, N. Perez, B. Udd, O. Danos, et al. Mannosidase I inhibition rescues the human {alpha}-sarcoglycan R77C recurrent mutation Hum. Mol. Genet., May 1, 2008; 17(9): 1214 - 1221. |
